|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Developing a containment strategy has become a moving target as the exposure limits for new drug compounds become increasingly low. Exposure limits of 10 micrograms were the exception five years ago, but today it is not uncommon for new drug compounds to have exposure limits in the low nanogram range. 'Exposure limit' is a term used to describe the quantity of drug a healthy individual can absorb without suffering a physical or mental effect. Exposure limits are set by the pharmaceutical manufacturing companies based on the information gathered during the development of the compound.
The exposure limit is based on both laboratory data and feedback gathered during clinical trials. The goal is to determine a 'no effect' level, or the maximum amount of the drug a person can be exposed to without seeing a measurable effect. Once a 'no effect' level is determined, a safety factor is selected based on the impact of exposure to the drug.
Most pharmaceutical companies use three categories in selecting safety factors. The three levels are: low impact, defined as not having a long-term effect and easily corrected; serious but not life threatening; and finally an effect which is either irreversible or life threatening. Typically, the quantity of drug creating the 'no effect' level will receive a safety factor of 10 times for low impact, 100 times for serious impact and 1,000 times for non-reversible or life threatening impacts.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Global Clinical Outsourcing Partnerships
26-27 March 2009, Mariott Hotel, Brussels
This Jacob Fleming event is designed to promote direct business. It features a two-day educational session with case studies, presentations and interactive sessions. This forum offers networking and the forging of new business partnerships in a unique business-driven environment.
More info >> |
|
 |
News and Press Releases |
 |
INTERLAB growing at a rate of 35%
24th November 2008
More info >> |
|
|
